Company Ticker News January 12, 20222 Monster Stocks to Buy for 2022 That Are Practically Minting Money 0 0 Share
Press Release January 11, 2022AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025 0 0 Share
Press Release January 7, 2022AbbVie Submits Applications for Upadacitinib (RINVOQ®) in Non-Radiographic Axial Spondyloarthritis to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) 0 0 Share
Company Ticker News January 5, 2022AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call 0 0 Share
Company Ticker News January 5, 2022AbbVie (ABBV) Gets FDA Breakthrough Tag for Lung Cancer Drug 0 0 Share
